Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) fell 8.1% during mid-day trading on Thursday . The company traded as low as $1.41 and last traded at $1.47. 738 shares traded hands during trading, a decline of 90% from the average session volume of 7,096 shares. The stock had previously closed at $1.60.
Nutriband Stock Performance
The stock has a 50 day moving average price of $1.50 and a two-hundred day moving average price of $1.31.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Further Reading
- Five stocks we like better than Nutriband
- Stock Splits, Do They Really Impact Investors?
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Investing In Automotive Stocks
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Canadian Penny Stocks: Can They Make You Rich?
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
